# Sprinklr, Inc.: financial statements, quarterly

CXM · NYSE · CIK 1569345 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/cxm.md) · [Financials](/companies/cxm/financials.md) · [Filings](/companies/cxm/filings.md) · [Insiders](/companies/cxm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cxm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [186](/filings/0001569345-24-000055.md) | [194 d](/filings/0001569345-26-000015.md) | [196](/filings/0001569345-25-000028.md) | [197](/filings/0001569345-25-000048.md) | [201](/filings/0001569345-25-000059.md) | [203 d](/filings/0001569345-26-000015.md) | [206](/filings/0001569345-26-000028.md) | [212](/filings/0001569345-26-000038.md) | [219](/filings/0001569345-25-000059.md) | [221 d](/filings/0001569345-26-000015.md) | [219](/filings/0001569345-26-000028.md) | [214](/filings/0001569345-26-000038.md) |
| Cost of revenue | $m | [46.4](/filings/0001569345-24-000055.md) | [47.5 d](/filings/0001569345-26-000015.md) | [51.1](/filings/0001569345-25-000028.md) | [54.0](/filings/0001569345-25-000048.md) | [57.8](/filings/0001569345-25-000059.md) | [58.8 d](/filings/0001569345-26-000015.md) | [62.6](/filings/0001569345-26-000028.md) | [67.4](/filings/0001569345-26-000038.md) | [73.6](/filings/0001569345-25-000059.md) | [75.8 d](/filings/0001569345-26-000015.md) | [76.4](/filings/0001569345-26-000028.md) | [74.6](/filings/0001569345-26-000038.md) |
| Gross profit | $m | [140](/filings/0001569345-24-000055.md) | [147 d](/filings/0001569345-26-000015.md) | [145](/filings/0001569345-25-000028.md) | [143](/filings/0001569345-25-000048.md) | [143](/filings/0001569345-25-000059.md) | [144 d](/filings/0001569345-26-000015.md) | [143](/filings/0001569345-26-000028.md) | [145](/filings/0001569345-26-000038.md) | [145](/filings/0001569345-25-000059.md) | [145 d](/filings/0001569345-26-000015.md) | [143](/filings/0001569345-26-000028.md) | [139](/filings/0001569345-26-000038.md) |
| Research and development | $m | [23.1](/filings/0001569345-24-000055.md) | [23.1 d](/filings/0001569345-26-000015.md) | [22.5](/filings/0001569345-25-000028.md) | [23.2](/filings/0001569345-25-000048.md) | [23.3](/filings/0001569345-25-000059.md) | [22.6 d](/filings/0001569345-26-000015.md) | [22.8](/filings/0001569345-26-000028.md) | [23.2](/filings/0001569345-26-000038.md) | [24.7](/filings/0001569345-25-000059.md) | [25.3 d](/filings/0001569345-26-000015.md) | [23.4](/filings/0001569345-26-000028.md) | [24.4](/filings/0001569345-26-000038.md) |
| Operating income | $m | [13.2](/filings/0001569345-24-000055.md) | [18.5 d](/filings/0001569345-26-000015.md) | [5.7](/filings/0001569345-25-000028.md) | [(0.1)](/filings/0001569345-25-000048.md) | [7.9](/filings/0001569345-25-000059.md) | [10.5 d](/filings/0001569345-26-000015.md) | [(1.8)](/filings/0001569345-26-000028.md) | [16.3](/filings/0001569345-26-000038.md) | [11.6](/filings/0001569345-25-000059.md) | [14.2 d](/filings/0001569345-26-000015.md) | [10.6](/filings/0001569345-26-000028.md) | [10.0](/filings/0001569345-26-000038.md) |
| Income tax | $m | [2.6](/filings/0001569345-24-000055.md) | [5.6 d](/filings/0001569345-26-000015.md) | [2.6](/filings/0001569345-25-000028.md) | [4.5](/filings/0001569345-25-000048.md) | [2.9](/filings/0001569345-25-000059.md) | [(83.3) d](/filings/0001569345-26-000015.md) | [6.7](/filings/0001569345-26-000028.md) | [11.1](/filings/0001569345-26-000038.md) | [14.4](/filings/0001569345-25-000059.md) | [11.6 d](/filings/0001569345-26-000015.md) | [12.1](/filings/0001569345-26-000028.md) | [5.6](/filings/0001569345-26-000038.md) |
| Net income | $m | [17.0](/filings/0001569345-24-000055.md) | [21.1 d](/filings/0001569345-26-000015.md) | [10.6](/filings/0001569345-25-000028.md) | [1.8](/filings/0001569345-25-000048.md) | [10.5](/filings/0001569345-25-000059.md) | [98.7 d](/filings/0001569345-26-000015.md) | [(1.6)](/filings/0001569345-26-000028.md) | [12.6](/filings/0001569345-26-000038.md) | [2.9](/filings/0001569345-25-000059.md) | [9.0 d](/filings/0001569345-26-000015.md) | [4.2](/filings/0001569345-26-000028.md) | [7.1](/filings/0001569345-26-000038.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001569345-24-000055.md) | not reported | [0.04](/filings/0001569345-25-000028.md) | [0.01](/filings/0001569345-25-000048.md) | [0.04](/filings/0001569345-25-000059.md) | not reported | [(0.01)](/filings/0001569345-26-000028.md) | [0.05](/filings/0001569345-26-000038.md) | [0.01](/filings/0001569345-25-000059.md) | not reported | [0.02](/filings/0001569345-26-000028.md) | [0.03](/filings/0001569345-26-000038.md) |
| Basic EPS | $ per share | [0.06](/filings/0001569345-24-000055.md) | not reported | [0.04](/filings/0001569345-25-000028.md) | [0.01](/filings/0001569345-25-000048.md) | [0.04](/filings/0001569345-25-000059.md) | not reported | [(0.01)](/filings/0001569345-26-000028.md) | [0.05](/filings/0001569345-26-000038.md) | [0.01](/filings/0001569345-25-000059.md) | not reported | [0.02](/filings/0001569345-26-000028.md) | [0.03](/filings/0001569345-26-000038.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [172](/filings/0001569345-23-000072.md) | [164](/filings/0001569345-25-000019.md) | [127](/filings/0001569345-24-000031.md) | [119](/filings/0001569345-24-000046.md) | [93.2](/filings/0001569345-24-000055.md) | [145](/filings/0001569345-26-000015.md) | [126](/filings/0001569345-25-000028.md) | [125](/filings/0001569345-25-000048.md) | [190](/filings/0001569345-25-000059.md) | [163](/filings/0001569345-26-000038.md) | [163](/filings/0001569345-26-000028.md) | [231](/filings/0001569345-26-000038.md) |
| Current assets | $m | [887](/filings/0001569345-23-000072.md) | [1,001](/filings/0001569345-25-000019.md) | [884](/filings/0001569345-24-000031.md) | [742](/filings/0001569345-24-000046.md) | [730](/filings/0001569345-24-000055.md) | [854](/filings/0001569345-26-000015.md) | [862](/filings/0001569345-25-000028.md) | [767](/filings/0001569345-25-000048.md) | [736](/filings/0001569345-25-000059.md) | [888](/filings/0001569345-26-000038.md) | [745](/filings/0001569345-26-000028.md) | [740](/filings/0001569345-26-000038.md) |
| Total assets | $m | [1,088](/filings/0001569345-23-000072.md) | [1,223](/filings/0001569345-25-000019.md) | [1,124](/filings/0001569345-24-000031.md) | [984](/filings/0001569345-24-000046.md) | [970](/filings/0001569345-24-000055.md) | [1,184](/filings/0001569345-26-000015.md) | [1,190](/filings/0001569345-25-000028.md) | [1,086](/filings/0001569345-25-000048.md) | [1,054](/filings/0001569345-25-000059.md) | [1,205](/filings/0001569345-26-000038.md) | [1,062](/filings/0001569345-26-000028.md) | [1,052](/filings/0001569345-26-000038.md) |
| Current liabilities | $m | [399](/filings/0001569345-23-000072.md) | [508](/filings/0001569345-25-000019.md) | [460](/filings/0001569345-24-000031.md) | [459](/filings/0001569345-24-000046.md) | [419](/filings/0001569345-24-000055.md) | [518](/filings/0001569345-26-000015.md) | [495](/filings/0001569345-25-000028.md) | [494](/filings/0001569345-25-000048.md) | [444](/filings/0001569345-25-000059.md) | [554](/filings/0001569345-26-000038.md) | [520](/filings/0001569345-26-000028.md) | [476](/filings/0001569345-26-000038.md) |
| Total liabilities | $m | [430](/filings/0001569345-23-000072.md) | [543](/filings/0001569345-25-000019.md) | [513](/filings/0001569345-24-000031.md) | [515](/filings/0001569345-24-000046.md) | [473](/filings/0001569345-24-000055.md) | [572](/filings/0001569345-26-000015.md) | [550](/filings/0001569345-25-000028.md) | [543](/filings/0001569345-25-000048.md) | [496](/filings/0001569345-25-000059.md) | [612](/filings/0001569345-26-000038.md) | [573](/filings/0001569345-26-000028.md) | [532](/filings/0001569345-26-000038.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [658](/filings/0001569345-24-000055.md) | [680](/filings/0001569345-26-000015.md) | [611](/filings/0001569345-25-000048.md) | [469](/filings/0001569345-25-000059.md) | [497](/filings/0001569345-25-000059.md) | [612](/filings/0001569345-26-000038.md) | [640](/filings/0001569345-26-000038.md) | [543](/filings/0001569345-26-000038.md) | [558](/filings/0001569345-25-000059.md) | [593](/filings/0001569345-26-000038.md) | [488](/filings/0001569345-26-000038.md) | [519](/filings/0001569345-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.0 d](/filings/0001569345-24-000055.md) | [17.3 d](/filings/0001569345-26-000015.md) | [41.7](/filings/0001569345-25-000028.md) | [21.3 d](/filings/0001569345-25-000048.md) | [9.2 d](/filings/0001569345-25-000059.md) | [5.4 d](/filings/0001569345-26-000015.md) | [83.8](/filings/0001569345-26-000028.md) | [34.8 d](/filings/0001569345-26-000038.md) | [20.0 d](/filings/0001569345-25-000059.md) | [20.7 d](/filings/0001569345-26-000015.md) | [70.4](/filings/0001569345-26-000028.md) | [18.2 d](/filings/0001569345-26-000038.md) |
| Capital expenditure | $m | [2.1 d](/filings/0001569345-24-000055.md) | [2.1 d](/filings/0001569345-26-000015.md) | [2.5](/filings/0001569345-25-000028.md) | [1.5 d](/filings/0001569345-25-000048.md) | [1.0 d](/filings/0001569345-25-000059.md) | [0.8 d](/filings/0001569345-26-000015.md) | [0.3](/filings/0001569345-26-000028.md) | [0.4 d](/filings/0001569345-26-000038.md) | [0.2 d](/filings/0001569345-25-000059.md) | [0.5 d](/filings/0001569345-26-000015.md) | [0.3](/filings/0001569345-26-000028.md) | [0.4 d](/filings/0001569345-26-000038.md) |
| Share repurchases | $m | [0.0 d](/filings/0001569345-24-000055.md) | [26.7 d](/filings/0001569345-26-000015.md) | [100.0](/filings/0001569345-25-000028.md) | [174 d](/filings/0001569345-25-000048.md) | [0.0 d](/filings/0001569345-25-000059.md) | [0.0 d](/filings/0001569345-26-000015.md) | [0.0](/filings/0001569345-26-000028.md) | [141 d](/filings/0001569345-26-000038.md) | [11.4 d](/filings/0001569345-25-000059.md) | [0.0 d](/filings/0001569345-26-000015.md) | [125](/filings/0001569345-26-000028.md) | [0.8 d](/filings/0001569345-26-000038.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [260](/filings/0001569345-23-000072.md) | [281](/filings/0001569345-24-000031.md) | [284](/filings/0001569345-24-000046.md) | [288](/filings/0001569345-24-000055.md) | [284](/filings/0001569345-25-000028.md) | [272](/filings/0001569345-25-000048.md) | [262](/filings/0001569345-25-000059.md) | [257](/filings/0001569345-26-000028.md) | [263](/filings/0001569345-26-000038.md) | [252](/filings/0001569345-25-000059.md) | [243](/filings/0001569345-26-000028.md) | [238](/filings/0001569345-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.